직장에 발생한 위장관 간질종양 7예

목차 (Table of Contents)

• 서론
• 방법
• 결과
• 고찰
• 결론
• REFERENCES

참고문헌 (Reference)

1 van Oosterom AT, "Update of phase I study of imatinib a report of the EOERTIC Soft Tissue and Bone Sarcoma Group" 38 : S83-7, 2002

2 DeMatteo RP, "Two hundred gastrointestinal tumors.Recurrence patterns and prognostic factors for survival" 231 : 51-8, 2000

3 Boudewijin E, "Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors:differences in clinical outcome and expression of multidrug resistance" 18 : 3211-20, 2000

4 van Oosterom AT, "Safety and efficacy of imatinib" 358 : 1421-3, 2001

5 Lewis JJ, "Retroperitoneal soft-tissue sarcoma:analysis of 500 patients treated and followed at a single institution" 228 : 355-65, 1998

6 Yoon SG, "Prognostic factors in gastrointestinal malignant stromal tumors" 51 : 181-95, 1996

7 Emory TS, "Prognosis of smooth-muscle Dependence on anatomic site" 23 : 82-7, 1999

8 Conlon KC, "Primary gastrointestinal sarcomas:analysis of prognostic variables" 2 : 26-31, 1995

9 Meijer S, "Primary colorectal sarcoma.A retrospective review and prognostic factor study of 50 consecutive patients" 125 : 1163-8, 1990

10 Meijer S, "Primary colorectal sarcoma.A retrospective review and prognostic factor study of 50 consecutive patients" 125 : 1163-8, 1990

11 Zalupski M, "Phase III comparison of doxorubicin and dacarbazine given by bolus versus iinfusion in patients with soft- tissue sarcomas:A Southwest Oncology Group study" 83 : 926-32, 1991

12 Joensuu H, "Management of malignant gastrointestinal stromal tumours" 3 : 655-64, 2002

13 Khalifa AA, "Leiomyosarcoma of the rectum" 29 : 427-32, 1986

14 Khalifa AA, "Leiomyosarcoma of the rectum" 29 : 427-32, 1986

15 Japues DP, "Hepatic metastases from soft-tissue sarcoma" 221 : 392-7, 1995

16 Miettinen M, "Gastrointestinal stromal tumours" 87 : 278-81, 1998

17 Markku M, "Gastrointestinal stromal tumors:recect advances in understanding of their biology" 309 : 1213-20, 1999

18 Lasota J, "Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis" 438 : 1-12, 2001

19 Saul S, "Gastrointestinal stromal tumors" 13 : 297-313, 1996

20 Nakayama T, "Gastrointestinal stromal tumor of the rectal mesentery" 38 : 186-9, 2003

21 Kim HC, "Gastrointestinal stromal tumor in stomach:A clinicopathologic and immunohistochemical study" 32 : 320-31, 1998

22 Ha DW, "Gastrointestinal Stromal Tumors; Clinicopathological Features and Prognostic Factors" 61 : 295-9, 2001

23 Mazur MT, "Gastric stromal tumors:Reappraisal of histogenesis" 7 : 507-19, 1983

24 Joensuu H, "Effect of tyrosine tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor" 344 : 1052-56, 2001

25 Franquemont DW, "Differentiation and risk assessment of gastrointestinal stromal tumors" 103 : 41-7, 1995

26 Fletcher CD, "Diagnosis of gastrointestinal stromal tumors:a consensus approach" 33 : 459-65, 2002

27 Fletcher CD, "Diagnosis of gastrointestinal stromal tumors:A consensus approach" 33 : 459-465, 2002

28 Minsky BD, "Conservative management of anal leiomyosarcoma" 68 : 1640-3, 1991

29 Hogenauer C, "Complete remission of a metastatic gastrointestinal stromal tumor with the tyrosine kinase inhibitor imatinib(STI571)effect of low dosage in an advanced tumour with exon 11 mutation" 15 : 323-7, 2003

30 Heinrich MC, "Biology and genetic aspects of gastrointestinal stromal tumors:KIT activation and cytogenetic alterations" 33 : 484-95, 2002

31 Yu CC, "A comparison of proliferating cell nuclear antigen and hisological grading in gastrointestinal tumors" immu (immu): 147-52, jpathol1992